Cancer & Hyperbarics

Mild hyperbaric oxygen therapy (mHBOT), which involves breathing pure oxygen in a pressurized chamber, is primarily used as an adjunctive treatment rather than a primary cure. For cancer patients, its benefits center on healing treatment-induced damage and potentially enhancing the efficacy of standard therapies. 

​

1. Healing Radiation-Induced Damage 

mHBOT is a proven treatment for Late Radiation Tissue Injury (LRTI), which occurs when radiation therapy damages blood vessels and causes tissue or bone death months or years after treatment. 

• Osteoradionecrosis (ORN): It helps heal radiation-damaged bone, most commonly in the jaw, by stimulating new blood vessel growth (angiogenesis).

• Soft Tissue Repair: It is effective for radiation-induced damage in the bladder (cystitis), bowel (proctitis), and chest wall, reducing symptoms like bleeding, pain, and swelling.

• Fibrosis Reduction: Research indicates mHBOT can significantly reduce radiation-induced skin fibrosis and lymphedema. 

  ​

2. Sensitizing Tumors to Treatment

Oxygen levels within a tumor significantly impact how well treatments work. mHBOT can address tumor hypoxia (low-oxygen areas), which often makes cancer cells resistant to traditional therapies. 

• Radiosensitization: Oxygen-rich cancer cells are more vulnerable to radiation. Using mHBOT immediately before radiation may improve local tumor control.

• Chemosensitization: By improving blood flow and oxygenation, mHBOT may enhance the penetration and toxic effect of certain chemotherapy drugs on cancer cells.

• Immunotherapy Support: Emerging research suggests mHBOT might reprogram the immunosuppressive tumor microenvironment, potentially boosting the effectiveness of PD-1/PD-L1 antibody therapies. 

  ​

3. Supportive Care and Recovery

• Wound Healing: It is often used before and after surgery to accelerate healing, particularly for skin grafts or flaps at risk of failure.

• Infection Control: High oxygen levels boost white blood cell activity, helping the body fight bacteria and prevent infections.

• Symptom Relief: Some patients report improvements in cancer-related fatigue and "chemo brain" (cognitive fog) following treatment sessions. 

  ​

4. Safety and Considerations

• Not a Cure: There is no strong scientific evidence that mHBOT cures cancer on its own.

• Growth Concerns: While earlier theories feared oxygen might "fuel" cancer growth, modern systematic reviews conclude that mHBOT does not promote tumor progression, recurrence, or metastasis.

• Contraindications: mHBOT should not be used with certain chemotherapy drugs (e.g., doxorubicin, bleomycin) as it may increase their toxicity. Always consult an oncologist before beginning treatment.

​